Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Evidence: Effectiveness and Safety of Repeated Low-Level Red-Light Therapy on Myopia Control Among Children and Adolescents

NCT05871840 is registered in ClinicalTrials.gov with Shenzhen Hospital (Guangming), University of Chinese Academy of Sciences as lead sponsor.

NCT NCT05871840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05871840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Evidence: Effectiveness and Safety of Repeated Low-Level Red-Light Therapy on Myopia Control Among Children and Adolescents
Lead sponsor
Shenzhen Hospital (Guangming), University of Chinese Academy of Sciences
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2023
Completion date
December 31, 2024
Enrollment
360 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

myopia